Thelypteris penangiana
Thelypteris penangiana · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Thelypteris penangiana is a botanical species that has gained attention for its significant medicinal potential through various chemical profiles. Research into its rhizome has identified key bioactive compounds, including flavanone, flavone, triphyllin A, and abacopterin A. When prepared as "Sanxuelian," acetone-H2O (4:1) extract, or methanol extract, the plant demonstrates potent antioxidant activities. These preparations have shown promise in addressing diverse physiological conditions such as inflammation, edema, and hypoglycemia. Furthermore, its therapeutic properties are being explored for the management of Benign Prostatic Hyperplasia.
- Synonyms
- Pronephrium Penangianum · Polypodium Lineatum Var. Penangianum · 22 more
- Common names
- Not available
- Family
- Aspleniaceae
- Distribution
- Not available
- Plant Parts
- Rhizome
Classification
Synonyms
Thelypteris penangiana is a botanical species that has been classified under several different names throughout its scientific history. It is recognized by various synonyms, including the designations Abacopteris penangiana and Cyclosorus penangianus. Taxonomic shifts have also linked this plant to Aspidium porphyrophlebium as well as Aspidium rampans. Furthermore, the species has been identified in literature as Christella porphyrophlebia. These varying nomenclatures reflect the complex evolving relationships found within fern taxonomy.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Thelypteris penangiana is a distinctive member of the kingdom Plantae. Within this vast biological realm, it is classified under the class Equisetopsida. This species belongs to the order Polypodiales, showcasing its evolutionary lineage. It is further categorized into the genus Thelypteris, which defines its specific botanical characteristics. Finally, this fern is a recognized part of the family Aspleniaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Polypodiinae |
| Order | Polypodiales |
| Family | Aspleniaceae |
| Genus | Thelypteris |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Thelypteris penangiana exhibits a broad geographical presence across various regions of Asia. In temperate climates, the species is found within specific areas of China, including both the South-Central and Southeast territories. Its reach extends significantly into tropical zones as well, particularly throughout the Indian Subcontinent. Within these tropical reaches, the plant thrives in the lush environments of Assam and the East Himalaya. Additionally, its documented distribution includes the diverse landscapes found throughout Nepal.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Thelypteris penangiana, also known as Abacopteris penangiana, has been identified as a source of significant antioxidant activity. Researchers isolated several flavonoid glycosides from the aerial parts of this fern through extensive spectroscopic analysis. Among the compounds found, five new flavan-4-ol glycosides were identified alongside several known derivatives. When these isolated glycosides were evaluated using the TEAC assay, multiple compounds demonstrated notable radical scavenging potential. This chemical profile highlights the plant's therapeutic promise due to its potent antioxidant properties.
Compounds
Thelypteris penangiana, also known as Abacopteris penangiana, serves as a rich source of diverse bioactive secondary metabolites. Research has successfully identified that the plant contains specific compounds such as flavone and flavanone, which exhibit significant antioxidant properties. Additionally, chemical analyses of its rhizomes have isolated triphyllin A and the novel flavonoid abacopterin A. These constituents are of particular interest due to their neuroprotective effects and potential to combat neurotoxicity. Furthermore, abacopterin A has demonstrated promising hypolipidemic and anti-inflammatory properties in experimental models.
Conditions
Thelypteris penangiana provides significant therapeutic benefits by treating H(2)O(2)-induced oxidative damage through the enhancement of antioxidant enzyme activities. Its bioactive compounds effectively address inflammation by inhibiting the expression of the nuclear transcription factor-κB (NFκB) signaling pathway. Additionally, the plant demonstrates potent anti-inflammation properties by reducing the levels of proinflammatory cytokines. These medicinal qualities allow it to successfully treat aortas injuries and mitigate overall aortic pathology in models of metabolic syndrome. Through these combined mechanisms, the plant serves as a potential herb for protecting vascular health and managing oxidative stress.
Preparations
Thelypteris penangiana, also referred to as Abacopteris penangiana, is traditionally prepared as "Sanxuelian" to treat conditions such as blood circulation stasis, edema, and inflammation. For scientific investigation, the plant is also prepared as an acetone-H2O (4:1) extract to isolate specific chemical constituents like 4'-hydroxy pneumatopterin B. Additionally, the rhizomes of the plant are prepared as a methanol extract to facilitate the isolation of various flavan-4-ol glycosides. These diverse preparation methods allow researchers to study the plant's therapeutic potential and complex chemical structures. Each extraction technique serves a specific purpose in identifying the bioactive compounds present within the species.
Parts used
Thelypteris penangiana, also known by its synonym Abacopteris penangiana, contains a significant rhizome component that serves as a rich source of bioactive compounds. Research has successfully isolated several new flavan-4-ol glycosides from the methanol extract of these rhizomes. In traditional Chinese medicine, the rhizome is known as "Sanxuelian" and is utilized to treat inflammation, edema, and blood circulation issues. Modern studies indicate that these rhizome extracts possess potent vascular protective, hypoglycemic, and anti-inflammatory properties. Furthermore, the flavan glycosides derived from the plant have demonstrated promising potential in treating benign prostatic hyperplasia.